---
$id: https://graph.org.ai/products/commodity/51182437
$type: Product
source: UNSPSC
code: "51182437"
title: "Cinacalcet hydrochloride"
class: "51182400"
classTitle: "Calcium regulators and calcium salts"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cinacalcet hydrochloride

**UNSPSC Code**: 51182437
**Class**: [Calcium regulators and calcium salts](Calcium regulators and calcium salts.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a malignancy-associated hypercalcemia inhibitor with the molecular formula C22H22F3N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1K860WSG25, chemically known as 1-naphthalenemethanamine, a-methyl-n-(3-(3-(trifluoromethyl)phenyl)propyl)-, (ar)-, hydrochloride but more generally known as cinacalcet hydrochloride, which bears US NIH Compound Identifier 156418. European Medicines Agency schedules Cinacalcet hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20068. Most nations, for tariff and trade purposes, schedule cinacalcet hydrochloride under HS 29214980 and SITC 51454. As of Q4 2014, CINACALCET HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Cinacalcet hydrochloride bears US NLM identifiers UMLS ID C1260199 and NCI Concept Code C47450. SMILES: C[C@H](C1CCCC2C1CCCC2)NCCCC3CCCC(C3)C(F)(F)F.CL.

